Perspectives

The 2028 US election cycle has already begun. This analysis provides a preview of the core narratives around industrial policy, tech regulation, and fiscal responsibility that will define future US policy shifts, offering a framework for long-term political risk monitoring.

AI-powered automated compliance monitoring is the only scalable solution for SMEs facing complex regulations like CSRD and CSDDD. Move beyond manual spreadsheets to a proactive, intelligent system for managing regulatory risk.

For startups, policy-market fit is a new, critical success factor. This post explains why early-stage startup policy monitoring is essential for managing regulatory risk and turning external threats into a competitive advantage.

Stop treating the EU's CSRD as a compliance chore. Learn how to use its continuous stream of regulatory, market, and stakeholder signals to pressure-test your ESG position paper, turning a reporting burden into a powerful strategic intelligence tool.

Moving beyond China? Learn to manage the hidden political, regulatory, and social threats in APAC's mineral hotspots. De-risk your 'China Plus One' strategy with proactive intelligence.

Relying on official records like Hansard is a strategic liability. Discover why modern UK public affairs teams must track MP social media and public signals to gain early warnings on policy shifts and emerging risks.

For UK businesses, the EU-Mercosur trade deal creates immediate tariff disadvantages but opens strategic post-Brexit opportunities. This analysis explores the competitive risks, the current status of the deal, and how UK firms can leverage agility to secure an advantage.

The rise of GLP-1s has fractured the patient advocacy landscape, creating new risks and opportunities for pharma. This case study analyzes the key advocacy archetypes shaping GLP-1 access policy and explains why dynamic, AI-driven intelligence is now essential.

Internal echo chambers create strategic blind spots that can derail even the most well-planned advocacy strategy. Learn why external validation is critical for success and how an external intelligence platform provides the continuous reality check needed to stay aligned, mitigate risks, and seize opportunities.

Discover why traditional stakeholder matrix mapping is a dangerously outdated tool for navigating the complex world of EU pharmaceutical policy. Learn how its static nature creates blind spots and why a shift to dynamic, AI-powered stakeholder intelligence is essential for success.